NCT03457610

Speech Therapy in the Management of Chronic Cough

Completed NA Last updated 15 April 2020

What this trial tests

NA trial testing Speech and language intervention in Cough in 30 participants. Completed in 30 January 2020.

Timeline

1 January 2016

Primary endpoint
30 December 2019

30 January 2020

Quick facts

Lead sponsor	Medical University of Warsaw
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 January 2016
Primary completion	30 December 2019
Estimated completion	30 January 2020
Sites	1 location across Poland

Drugs / interventions tested

• Speech and language intervention

Conditions studied

• Cough — all drugs for Cough →
• Speech Therapy — all drugs for Speech Therapy →

Sponsor

Medical University of Warsaw

Who can join

Adults 18 to 80, any sex, with Cough or Speech Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Speech and language intervention (speech therapy) is one of the few methods which seem to be useful in management of persistent chronic cough. This method has not been available for patients with cough in Poland so far.The aim of the study is to implement speech therapy to the management plan of patients with difficult-to-treat chronic cough and to analyze its efficacy in this particular group.

Patients with difficult-to treat chronic cough will be offered speech and language intervention as an added therapy. The effectiveness of speech therapy will be measured by changes in cough severity, its influence on quality of life and cough challenge test before and after speech therapy measured in every patient.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Speech and language therapy for management of chronic cough.
   Slinger C, Mehdi SB, Milan SJ, Dodd S, et al · · 2019 · cited 25× · PMID 31335963 · DOI 10.1002/14651858.cd013067.pub2